Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Bucyrus › NPI 1104914274
Hospital

Bucyrus Community Hospital LLC

Bucyrus Community Hospital LLC was paid $10.19M by Medicaid between Jan 2018 and Dec 2024, across 220 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 17% of everything it billed.

33Billing provider infoBUCYRUS COMMUNITY HOSPITAL LLC
BUCYRUS, OH 44820
33aNPI1104914274assigned 10/11/2006
33bProvider typeCritical Access Hospital
28Total paid$10.19M
24GClaims263,286
24DCodes billed220
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Ohio

Rank by total paid#6 of 26
Median peer was paid$5.33M
This provider vs. median1.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201818,061$675K
201916,282$618K
202014,960$717K
202117,746$857K
202222,767$1.06M
2023100,462$3.18M
2024incomplete73,008$3.09M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 17% 20,203 16,936 $1.73M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 14,531 13,454 $1.62M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 13% 18,963 4,798 $1.33M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.9% 6,883 6,153 $802K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.1% 4,194 3,588 $517K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 4.0% 4,820 4,298 $407K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.7% 4,116 3,212 $279K
20611 2.2% 1,138 904 $224K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.2% 2,145 1,999 $223K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.0% 1,274 623 $206K
70450 Computed tomography, head or brain; without contrast material 1.9% 765 637 $195K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 1.9% 5,765 1,462 $193K
208 more codes
74176 Computed tomography, abdomen and pelvis; without contrast material 1.8% 672 $182K
96361 Intravenous infusion, hydration; each additional hour 1.6% 476 $158K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.4% 535 $140K
80053 Comprehensive metabolic panel 1.1% 8,702 $110K
20610 1.0% 1,072 $104K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.0% 3,378 $103K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 1,688 $95K
97161 <1% 1,575 $91K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 613 $88K
99214 Doctor's office visit, returning patient (more involved) <1% 1,265 $87K
G0378 Hospital observation service, per hour <1% 1,804 $75K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,927 $53K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 778 $52K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 15,413 $41K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,858 $41K
80061 Lipid panel <1% 3,411 $41K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 825 $39K
84443 Thyroid stimulating hormone (TSH) <1% 2,365 $38K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 161 $36K
81003 <1% 1,560 $34K
97162 <1% 904 $34K
36415 Collection of venous blood by venipuncture <1% 16,766 $30K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 838 $28K
83036 Hemoglobin; glycosylated (A1C) <1% 2,133 $27K
90670 <1% 970 $27K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 1,068 $26K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,217 $25K
71046 Radiologic examination, chest; 2 views <1% 1,081 $24K
76000 <1% 327 $24K
52000 <1% 113 $23K
83735 <1% 4,459 $23K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 809 $22K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,820 $22K
92526 <1% 361 $21K
71275 Computed tomographic angiography, chest, with contrast material <1% 58 $21K
76830 Ultrasound, transvaginal <1% 154 $19K
71250 <1% 323 $19K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 3,648 $18K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 230 $17K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 2,143 $15K
97165 <1% 250 $14K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 49 $13K
97014 <1% 383 $13K
77063 Screening digital breast tomosynthesis, bilateral <1% 245 $12K
80069 <1% 1,367 $11K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,197 $11K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 20 $11K
97016 <1% 336 $10K
80048 Basic metabolic panel (calcium, ionized) <1% 1,018 $10K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 50 $10K
86140 <1% 1,127 $10K
97032 <1% 138 $9K
82607 <1% 550 $9K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,970 $9K
90686 <1% 527 $8K
97760 <1% 75 $8K
J3490 Unclassified drugs <1% 753 $7K
90633 <1% 298 $6K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 46 $6K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 604 $6K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,428 $6K
84439 <1% 327 $6K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,748 $6K
87150 <1% 686 $6K
82570 <1% 705 $5K
82728 <1% 425 $5K
85027 <1% 652 $5K
73564 <1% 446 $5K
99215 Doctor's office visit, returning patient (complex) <1% 77 $5K
71045 Radiologic examination, chest; single view <1% 1,915 $5K
73030 <1% 350 $5K
83540 <1% 592 $5K
73630 <1% 491 $4K
72125 Computed tomography, cervical spine; without contrast material <1% 233 $4K
81001 <1% 3,321 $3K
77067 Screening mammography, bilateral, including computer-aided detection <1% 246 $3K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 35 $3K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 31 $3K
73610 <1% 386 $3K
82746 <1% 454 $3K
20605 <1% 41 $3K
82043 <1% 446 $3K
84153 <1% 195 $3K
83550 <1% 457 $3K
97803 <1% 40 $3K
85610 <1% 1,612 $3K
80076 <1% 1,568 $3K
51798 <1% 199 $3K
72110 <1% 79 $3K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 2,041 $3K
82565 <1% 3,218 $3K
80051 <1% 3,074 $3K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 1,119 $3K
86803 <1% 157 $2K
94664 <1% 211 $2K
86850 <1% 92 $2K
73110 <1% 184 $2K
90698 <1% 574 $2K
84484 <1% 1,932 $2K
73502 <1% 144 $2K
85652 <1% 918 $2K
80305 <1% 998 $2K
87070 <1% 843 $2K
83880 <1% 442 $2K
90680 <1% 602 $2K
72131 <1% 26 $2K
87088 <1% 482 $2K
84100 <1% 266 $1K
73130 <1% 221 $1K
86900 <1% 131 $1K
96375 Therapeutic injection; each additional sequential IV push <1% 1,906 $1K
76770 <1% 12 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 85 $1K
87340 <1% 77 $1K
87186 <1% 698 $1K
84156 <1% 356 $1K
96376 <1% 717 $1K
82948 <1% 1,600 $1K
90472 Immunization administration, each additional vaccine (list separately) <1% 1,610 $1K
81025 <1% 1,486 $1K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 52 $1K
90715 <1% 80 $1K
84300 <1% 305 $984.18
82947 <1% 3,086 $926.53
97116 <1% 32 $814.77
84520 <1% 3,103 $805.13
82550 <1% 167 $790.94
80344 <1% 60 $760.49
84550 <1% 144 $737.10
84460 <1% 144 $691.97
97166 <1% 25 $683.19
90744 <1% 210 $657.46
96367 <1% 14 $620.20
85730 <1% 637 $619.23
90696 <1% 32 $614.68
86901 <1% 131 $588.82
83690 <1% 1,545 $558.96
86701 <1% 37 $537.39
72100 <1% 15 $518.62
86704 <1% 39 $490.96
82784 <1% 44 $488.43
83605 <1% 823 $487.47
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 195 $434.45
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 725 $419.22
97535 Self-care/home management training, each 15 minutes <1% 17 $398.24
90651 <1% 25 $384.62
90681 <1% 84 $382.14
86706 <1% 37 $327.04
87040 <1% 341 $313.51
84450 <1% 73 $297.45
82803 <1% 341 $294.81
86708 <1% 36 $280.62
90656 <1% 29 $259.71
J7030 Infusion, normal saline solution , 1000 cc <1% 1,868 $258.63
90697 <1% 71 $237.84
86038 <1% 14 $232.12
90474 <1% 431 $223.14
82248 <1% 38 $219.25
85378 <1% 350 $213.96
84703 <1% 160 $193.63
84238 <1% 13 $177.63
90734 <1% 47 $165.05
84145 <1% 41 $159.64
87449 <1% 19 $135.06
J1170 Injection, hydromorphone, up to 4 mg <1% 665 $127.57
80348 <1% 358 $121.17
87077 <1% 95 $107.07
J2704 Injection, propofol, 10 mg <1% 1,239 $92.78
90685 <1% 15 $81.89
90710 <1% 31 $80.06
85045 <1% 29 $75.95
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 63 $66.00
J1650 Injection, enoxaparin sodium, 10 mg <1% 277 $63.32
87205 <1% 90 $59.35
J2270 Injection, morphine sulfate, up to 10 mg <1% 154 $50.15
J1030 Injection, methylprednisolone acetate, 40 mg <1% 72 $47.77
J7120 Ringers lactate infusion, up to 1000 cc <1% 501 $39.29
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,039 $35.51
80354 <1% 84 $28.48
J3010 Injection, fentanyl citrate, 0.1 mg <1% 813 $27.30
87481 <1% 17 $26.73
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,150 $23.17
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 828 $23.12
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 250 $22.96
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 218 $14.52
J3370 Injection, vancomycin hcl, 500 mg <1% 112 $11.91
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 134 $4.79
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 198 $4.59
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 66 $4.34
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 400 $3.83
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 47 $3.60
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 609 $3.23
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 305 $2.51
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 46 $2.22
J1171 Injection, hydromorphone, 0.1 mg <1% 67 $1.35
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 1,344 $0.00
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 0% 13 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 94 $0.00
90461 0% 14 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 71 $0.00
00142 0% 18 $0.00
94761 0% 182 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 41 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 40 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 30 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 39 $0.00
G0009 Administration of pneumococcal vaccine 0% 29 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDRAIME, D. (CHIEF FINANCIAL OFFICER)